Abstract It was previously demonstrated that brief (B1 h) exposures to echinocandins are as effective to kill Candida albicans cells as continuous 24-h exposure. However, killing rates after continuous and short (1 h) echinocandin exposures to C. albicans have not yet been evaluated in RPMI-1640 with and without 50 % serum. We evaluated four echinocandin susceptible C. albicans bloodstream isolates, ATCC 10231 type strain and an echinocandin-resistant isolate (DPL20, FKS F645P). Caspofungin MICs, time-kill and postantifungal effect (PAFE) tests were performed in RPMI-1640 with and without 50 % serum. Killing rates (k values) in time-kill and PAFE experiments were determined for each strain and concentration. In time-kill experiments, colony count decreases were isolate-and concentration-dependent at 0.25, 1, 4, 8, 16 and 32 mg/L in RPMI-1640, but concentrationindependent at 1, 4, 8, 16 and 32 mg/L in 50 % serum. One-hour caspofungin exposure at 4, 16 and 32 mg/L resulted in CFU decreases comparable with the results obtained in time-kill experiments in RPMI-1640, but 50 % serum at 4, 16 and 32 mg/L allowed growth of all isolates (k values were negative) (P \ 0.05-0.001). PAFE in 50 % serum decreased markedly at 4, 16 and 32 mg/L. Killing rates remained high and concentration-independent in 50 % serum in case of continuous but not in case of brief caspofungin exposure. As only a short growth inhibition without killing was observed in 50 % serum, clinical relevance of caspofungin PAFE in vivo is questionable.
Introduction
Echinocandins (caspofungin, micafungin and anidulafungin) are reported to exhibit concentration-dependent fungicidal or fungistatic activity against the majority of Candida species. Additionally, echinocandins exert prolonged postantifungal effect (PAFE) after short (1 h) echinocandin exposure against many Candida species, including C. parapsilosis [1] [2] [3] [4] . Recent in vitro findings with RPMI-1640 suggest that a very short (B1 h) exposure to caspofungin kills Candida cells as effectively as a continuous 24-h exposure [5] . As echinocandins are highly proteinbound (C96.5 %) agents (i.e., serum fundamentally influences killing activities of echinocandins) [6] [7] [8] , we compared killing rates produced by short (1 h) and continuous (24 h) caspofungin exposure as well as PAFE in RPMI-1640 and 50 % serum against C. albicans.
Materials and Methods

Isolates
All C. albicans originated from blood samples ( Table 1 ) and were identified as described previously [9] . ATCC 10231 and an echinocandin-resistant isolate (DPL20, FKS F645P) were also included in the study.
MIC Determination
Caspofungin (Sigma, Budapest, Hungary) MICs in RPMI-1640 with and without 50 % human serum (from a human male, type AB, Sigma, Budapest, Hungary) were determined using the CLSI broth macrodilution method [6] [7] [8] 10] . Caspofungin final concentration ranged between 0.015 and 32 mg/L. MICs were read after 24 h using the partial inhibition criterion [10] .
Postantifungal Effect and Time-Kill Curves PAFE was measured in both media simultaneously. As in our preliminary experiments 5-, 10-and 30-min exposures to 0.5, 1 or 2 mg/L caspofungin did not produce measurable PAFEs in 50 % serum (1-16 9 MIC in 50 % serum), we used caspofungin at 4, 16 and 32 mg/L concentrations with a 60-min exposure time (brief caspofungin exposure) [3] [4] [5] . As the maximum administrable daily 150-200 mg caspofungin doses produce 30.4-40.6 mg/L geometric mean of peak concentrations in humans [11] , the highest caspofungin concentration used in this study was 32 mg/L [6] .
The starting inocula in PAFE experiments were 1-5 9 10 5 cells/ml [3] [4] [5] . After 1 h, the cells were collected by centrifugation at 1.5009g for 10 min and were washed three times with sterile saline, resuspended in 10 ml drug-free warm RPMI-1640 with and without 50 % human serum. Samples (100 ll) were removed at 0, 4, 8, 12 and 24 h, serially diluted tenfold, plated (4 9 30 ll) onto Sabouraud dextrose agar and incubated at 35°C for 48 h [3] [4] [5] .
For time-kill assays (continuous 24-h caspofungin exposure), test solutions were not centrifuged or washed. We used 0.25, 1, 4, 8, 16 and 32 mg/L caspofungin. In case of isolate DPL20, we used 4, 8, 16 and 32 mg/L caspofungin. Otherwise, the method was the same as described for PAFE [3] [4] [5] . All experiments were performed at least twice, and means of data are presented. Killing kinetics was analyzed mathematically, as described previously [6, 12] . An exponential equation was fitted to the mean data at each time point: N t = N 0 9 e -kt , where N t is the number of viable yeasts at time t, N 0 is the number of viable yeasts in the initial inoculum, k is the killing rate and t is the incubation time. Negative k values indicate growth, and positive k values indicate killing. The goodness of fit for each isolate was assessed by the r 2 value ([0.8) [6, 12] . PAFE was defined as the difference between the time required for control and test isolates to grow 1 log 10 following drug removal [3] [4] [5] . One-way ANOVA with Tukey's posttesting was used to analyze differences in killing rates by concentrations in either RPMI-1640 or 50 % serum [6] . Paired T test was used to compare the effect of the medium as well as the killing and growth rates in timekill and PAFE experiments at the same drug concentration.
Results
Susceptibility
MIC values are presented in Table 1 . Paradoxical growth was not observed. Clinical isolates and 10231 ATCC strain were susceptible to caspofungin 
according to the revised CLSI break-points in RPMI-1640 [13] . As expected, the DPL20 isolate with a prominent fks mutation was resistant to caspofungin [13] . MIC values were 4-to 16-fold higher in the presence of 50 % serum.
Time-Kill Experiments
In time-kill experiments, caspofungin was fungistatic at C1-29 MIC in both media against the clinical isolates as well as against the 10231 ATCC strain (\99.9 % reduction in viable cell count compared to the starting inoculum) ( Table 1 ; Fig. 1A , B, D, E). Against the resistant strain DPL20, caspofungin produced a weak fungistatic effect in RPMI-1640 (Fig. 1C) . In 50 % serum, the killing curves were generally similar to control; at 32 mg/L, a negligible reduction was observed after 4 h, but later the killing curves again became similar to control (Fig. 1F) .
Postantifungal Effect
The time required for control (drug-free) isolates to grow 1 log 10 was similar in both media (4.12-4.95 h in RPMI-1640 and 4.69-5.17 h in 50 % serum). PAFE plots for isolates 183 and 3666 in RPMI-1640 and in 50 % serum are shown in Fig. 2 Table 2) . PAFE in 50 % serum decreased markedly at 4, 16 and 32 mg/L concentrations (Table 2 ; Fig. 2 ). Most isolates showed growth in 50 % serum; colony count decreases occurred only in cases of isolates 183 at 16 and 32 mg/L (Fig. 2C ) and 3666 at 32 mg/L (Fig. 2D ) and only after 4 h and were negligible (Table 3 ). In case of DPL20, isolate PAFE was never observed regardless of media ( Table 2) .
Comparison of Colony Count Changes in TimeKill and Postantifungal Effect Experiments
Maximum colony count changes compared to the starting inocula in time-kill and PAFE experiments at 4, 16 and 32 mg/L are presented in Table 3 .
Comparing the different media at the same concentrations in killing experiments, the CFU decrease was generally higher in 50 % serum than in RPMI-1640 (Table 3) . Contrastingly, the CFU decrease in PAFE experiments was significantly higher in RPMI-1640 than in 50 % serum with all isolates and concentrations (P \ 0.05-0.001) ( Table 3) .
Comparing the colony counts reductions at the same concentrations in PAFE and time-kill experiments, we noticed comparable or sometimes higher reductions (in cases of 10920 and 3666 isolates) in PAFEs than that seen with continuous 24-h exposure in RPMI-1640 (Table 3) . However, 50 % serum significantly decreased the PAFE killing for all tested isolates (P \ 0.01-0.001) ( Table 3 ; Fig. 4A-E) .
Killing Rates in Time-Kill Experiments
In time-kill experiments, killing activity of caspofungin was significantly weaker at 16-32 mg/L than at 0.25, 1, 4 and 8 mg/L (P \ 0.05-0.001) in RPMI-1640 (mini-paradoxical effect) (Fig. 3A) . However, killing rates at 1-32 mg/L were concentration-independent in 50 % serum against the susceptible isolates (Fig. 3D) . Similar effect was noticed in case of the strain ATCC 10231 (Fig. 3C, F) . In case of isolate, DPL20 k values were negative (indicating the growth instead of killing) regardless of media (Fig. 3B, E) .
Killing Rates in Postantifungal Effect Experiments
In PAFE experiments, killing rates for clinical isolates and the ATCC strain in RPMI-1640 were isolate-and concentration-dependent (k values from -0.111 to ?1.019 1/h), while in 50 % serum, the k values showed markedly narrower range (from -0.017 to -0.185 1/h) ( Fig. 4A-E) .
Discussion
This study is the first in which killing rates in short and continuous caspofungin exposures to C. albicans were 
compared head to head in RPMI-1640 with and without 50 % serum. In agreement with previous results [3] [4] [5] , the CFU decreases in time-kill and PAFE experiments were similar in RPMI-1640; however, at 16 and 32 mg/L, killing rates decreased. Decreased killing rates in time-kill experiments at 16 and 32 mg/L can be explained by the adaptive and compensatory response to high caspofungin concentrations in the fungal cells that limit killing effect and allow for the growth [14] . Addition of 50 % serum significantly decreased killing rates at 4, 16 and 32 mg/L in the PAFE experiments as compared to RPMI-1640, while the killing rates in time-kill experiments (continuous exposure) at C1 mg/L concentrations remained high and concentration-independent (i.e., killing rate reached its maximum at 1 mg/L). These findings are in accordance with our previous results, where killing rates of C. krusei and C. inconspicua did not differ significantly in 50 % serum at effective concentrations [6] . Moreover, 1-h exposure of C. albicans to 0.5, 1 and 2 mg/L of caspofungin in 50 % serum is not long enough to produce any growth inhibition, as opposed to what found with RPMI-1640 alone. Louie et al. [15] demonstrated that tissues serve as drug reservoirs from which the drug is released slowly, explaining that serum caspofungin half-life tripled when both serum and tissues half-life were taken into account in the terminal half-life calculation. They concluded that the primary tissue reservoir rather than PAFE was responsible for the excellent in vivo activity of caspofungin [15] . Their results are in line with the present study, as 1-h exposure to caspofungin produced negative k values (growth) and significantly decreased PAFEs in 50 % serum.
PAFE is frequently regarded as a contributor to clinical efficacy of echinocandins [1] [2] [3] [4] 13] . It is defined as prolonged growth inhibition following limited (generally 1 h) in vitro drug exposure; however, it must be noted that this is not equal to killing, as slower growth may also be regarded as prominent PAFE. While killing may directly lead to eradication, growth, even slower growth, of fungi still carries a risk of persistent infection and fungal re-growth. These facts should be taken into consideration when translating PAFE as a contributor to clinical efficacy. Present results strongly suggest that PAFE is lost in the presence of 50 % serum, even though marked PAFE is detected in RPMI-1640 after 5-min exposure [5] . The negligible PAFEs found in 50 % serum indicate that prolonged in vitro PAFEs (in RPMI-1640), frequently interpreted as a contributor to better clinical efficacy [1] [2] [3] [4] , may be less important in vivo (better mimicked by the serum-containing medium) at least against C. albicans. Whether these also apply for albicans species is to be answered by further studies.
In summary, continuous but not brief caspofungin exposure produced measurable killing rates against C. albicans clinical isolates in killing studies in the presence of 50 % serum. PAFE after brief exposure to caspofungin (and probably to other echinocandins), even when marked, may play a limited role in the excellent clinical efficacy of echinocandins.
